Skip to main content
Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ: VNDA · Real-Time Price · USD
6.85
+0.01 (0.15%)
Apr 29, 2026, 2:10 PM EDT - Market open

Vanda Pharmaceuticals Revenue

In the year 2025, Vanda Pharmaceuticals had annual revenue of $216.11M with 8.72% growth. Vanda Pharmaceuticals had revenue of $57.22M in the quarter ending December 31, 2025, with 7.58% growth.

Revenue (ttm)
$216.11M
Revenue Growth
+8.72%
P/S Ratio
1.87
Revenue / Employee
$405,450
Employees
533
Market Cap
404.89M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025216.11M17.33M8.72%
Dec 31, 2024198.77M6.13M3.18%
Dec 31, 2023192.64M-61.74M-24.27%
Dec 31, 2022254.38M-14.30M-5.32%
Dec 31, 2021268.68M20.51M8.27%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Puma Biotechnology 228.37M
Niagen Bioscience 129.42M
Century Therapeutics 109.16M
Autolus Therapeutics 75.39M
Enanta Pharmaceuticals 66.98M
Invivyd 53.43M
Lineage Cell Therapeutics 14.56M
PureTech Health 6.39M
Revenue Rankings

VNDA News

More News